Velan Capital Investment Management LP

Position in ADMA — Adma Biologics, Inc.

CIK 1848809 ALPHARETTA, GA

Position in ADMA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,092,500

-$7,996,266 QoQ

Shares Held

250,000

-83.6% QoQ

Ownership

0.112%

of shares outstanding

% of Portfolio

1.28%

of 13F equity value

Holder Rank

#78

of 323 holders

Holding Since

Dec 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Velan Capital Investment Management LP holds $153,684,284 across 45 Biotechnology names. ADMA ranks #17 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PRAX	Praxis Precision Medicines, Inc.	88,781	$29,722,990
2	MPLT	MapLight Therapeutics, Inc.	492,893	$17,665,285
3	STRO	Sutro Biopharma, Inc.	512,160	$17,003,712
4	IMMX	Immix Biopharma, Inc.	1,085,000	$11,186,350
5	TARA	Protara Therapeutics, Inc.	2,844,652	$10,866,570
6	ABVX	Abivax S.A.	65,630	$8,745,853
7	TENX	Tenax Therapeutics, Inc.	549,985	$8,002,281
8	EDSA	Edesa Biotech, Inc.	827,500	$6,727,575

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,092,500	250,000	-83.6%	Shares	Sole	2026-08-14
2024-03-31	$10,088,766	1,528,601	-28.4%	Shares	Sole	2024-05-14
2023-12-31	$9,655,172	2,136,100	+23.0%	Shares	Sole	2024-02-14
2023-09-30	$6,215,238	1,736,100	-36.3%	Shares	Sole	2023-11-13
2023-06-30	$10,059,128	2,726,051	-31.8%	Shares	Sole	2023-08-11
2023-03-31	$13,240,000	4,000,000	0.0%	Shares	Sole	2023-05-15
2022-12-31	$15,520,000	4,000,000	-24.1%	Shares	Sole	2023-02-13
2022-09-30	$12,804,046	5,269,155	-13.2%	Shares	Sole	2022-11-14
2022-06-30	$12,025,724	6,073,598	+4.3%	Shares	Sole	2022-08-15
2022-03-31	$10,655,720	5,822,798	+7.9%	Shares	Sole	2022-05-16
2021-12-31	$7,610,895	5,397,798	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.